Endotoxemia related to cardiopulmonary bypass is associated with increased risk of infection after cardiac surgery: A prospective observational study

Critical Care

Volumn 15, Issue 1, 2011, Pages

  Klein, David J ^a   Briet, Francoise ^b   Nisenbaum, Rosane ^c   Romaschin, Alexander D ^a   Mazer, C David ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN;

ADULT; ANESTHESIA INDUCTION; AORTA CLAMPING; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS GRAFT; ENDOTOXEMIA; FEMALE; HEART SURGERY; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PERIOPERATIVE PERIOD; POSTOPERATIVE INFECTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; AGED; BLOOD; ELECTIVE SURGERY; INFECTION; MIDDLE AGED; RISK ASSESSMENT; STATISTICS;

AGED; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; ENDOTOXEMIA; ENDOTOXINS; FEMALE; HUMANS; INFECTION; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURGICAL PROCEDURES, ELECTIVE;

EID: 79951849926     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10051     Document Type: Article

References (31)

1. Gibbon J. The development of the heart-lung-apparatus. American Journal of Surgery 1978, 135:608-619. 10.1016/0002-9610(78)90119-8, 347960.
2. Utley JR. The history of the concept of inflammatory responses to cardiopulmonary bypass. Perfusion 1996, 11:190-195. 10.1177/026765919601100303, 8817626.
3. Warren OJ, Smith AJ, Alexiou C, Rogers PL, Jawad N, Vincent C, Darzi AW, Athanasiou T. The inflammatory response to cardiopulmonary bypass: part 1-mechanisms of pathogenesis. J Cardiothorac Vasc Anesth 2009, 23:223-231. 10.1053/j.jvca.2008.08.007, 18930659.
4. Antonelli M, Testa G, Tritapepe L, D'Errico RR, Costa D, Giovannelli L, Riccioni L, Gasparetto A, Catena G. IL-8, IL-6 and ICAM-1 in serum of paediatric patients undergoing cardiopulmonary bypass with and without cardiocirculatory arrest. J Cardiovasc Surg (Torino) 1999, 40:803-809.
5. Holzheimer RG, Molloy RG, Gorlach H, Wilkert S, Hehrlein F. IL-6 and TNF alpha release in association with neutrophil activation after cardiopulmonary bypass surgery. Infection 1994, 22:37-42. 10.1007/BF01780764, 8181840.
6. Roth-Isigkeit A, Borstel TV, Seyfarth M, Schmucker P. Perioperative serum levels of tumour-necrosis-factor alpha (TNF-alpha), IL-1 beta, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution. Clin Exp Immunol 1999, 118:242-246. 10.1046/j.1365-2249.1999.01050.x, 1905422, 10540185.
7. Beutler BA. TLRs and innate immunity. Blood 2009, 113:1399-1407. 10.1182/blood-2008-07-019307, 2644070, 18757776.
8. Rocke DA, Gaffin SL, Wells MT, Koen Y, Brock-Utine JG. Endotoxemia associated with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1987, 93:832-837.
9. Riddington DW, Venkatesh B, Boivin CM, Bonser RS, Elliott TS, Marshall T, Mountford PJ, Bion JF. Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. JAMA 1996, 275:1007-1012. 10.1001/jama.275.13.1007, 8596232.
10. Bennett-Guerrero E, Grocott HP, Levy JH, Stierer KA, Hogue CW, Cheung AT, Newman MF, Carter AA, Rossignol DP, Collard CD. A phase II, double-blind, placebo-controlled, ascending-dose study of Eritoran (E5564), a lipid A antagonist, in patients undergoing cardiac surgery with cardiopulmonary bypass. Anesth Analg 2007, 104:378-383. 10.1213/01.ane.0000253501.07183.2a, 17242095.
11. Bouter H, Schippers EF, Luelmo SA, Versteegh MI, Ros P, Guiot HF, Frolich M, van Dissel JT. No effect of preoperative selective gut decontamination on endotoxemia and cytokine activation during cardiopulmonary bypass: a randomized, placebo-controlled study. Crit Care Med 2002, 30:38-43. 10.1097/00003246-200201000-00006, 11905407.
12. Neuhof C, Wendling J, Dapper F, Bauer J, Zickmann B, Jochum M, Tillmanns H, Neuhoft H. Endotoxemia and cytokine generation in cardiac surgery in relation to flow mode and duration of cardiopulmonary bypass. Shock 2001, 16(Suppl 1):39-43.
13. Elin RJ, Robinson RA, Levine AS, Wolff SM. Lack of clinical usefulness of the limulus test in the diagnosis of endotoxemia. N Engl J Med 1975, 293:521-524. 10.1056/NEJM197509112931102, 1152876.
14. Romaschin AD, Harris DM, Ribeiro MB, Paice J, Foster DM, Walker PM, Marshall JC. A rapid assay of endotoxin in whole blood using autologous neutrophil dependent chemiluminescence. J Immunol Methods 1998, 212:169-185. 10.1016/S0022-1759(98)00003-9, 9672205.
15. Jansen PG, Te H, Oudemans-Van HM, Bulder ER, Van Deventer SJ, Sturk A, Eijsman L, Wildevuur CR. Perfusion-related factors of endotoxin release during cardiopulmonary bypass. Eur J Cardiothorac Surg 1994, 8:125-129. 10.1016/1010-7940(94)90167-8, 8011344.
16. Boelke E, Storck M, Buttenschoen K, Berger D, Hannekum A. Endotoxemia and mediator release during cardiac surgery. Angiology 2000, 51:743-749. 10.1177/000331970005100906, 10999615.
17. Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, Opal S, Abraham E, Brett SJ, Smith T, Mehta S, Derzko A, Romaschin A, . MEDIC study Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 2004, 190:527-534. 10.1086/422254, 15243928, MEDIC study.
18. Sakata M, Inoue T, Todokoro M, Kunitake M. Limulus amebocyte lysate assay for endotoxins by an adsorption method with polycation-immobilized cellulose beads. Anal Sci 26:291-296. 10.2116/analsci.26.291, 20215676.
19. Jameel S, Colah S, Klein AA. Recent advances in cardiopulmonary bypass techniques. Contin Educ Anaesth Crit Care Pain 2010, 10:20-23.
20. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999, 115:829-835. 10.1378/chest.115.3.829, 10084499.
21. Charalambous BM, Stephens RC, Feavers IM, Montgomery HE. Role of bacterial endotoxin in chronic heart failure: the gut of the matter. Shock 2007, 28:15-23. 10.1097/shk.0b013e318033ebc5, 17510602.
22. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJ, Anker SD. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999, 353:1838-1842. 10.1016/S0140-6736(98)09286-1, 10359409.
23. Bennett-Guerrero E, Ayuso L, Hamilton-Davies C, White WD, Barclay GR, Smith PK, King SA, Muhlbaier LH, Newman MF, Mythen MG. Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. JAMA 1997, 277:646-650. 10.1001/jama.277.8.646, 9039883.
24. Faist E, Baue AE, Dittmer H, Heberer G. Multiple organ failure in polytrauma patients. J Trauma 1983, 23:775-787. 10.1097/00005373-198309000-00002, 6620431.
25. Winchurch RA, Thupari JN, Munster AM. Endotoxemia in burn patients: levels of circulating endotoxins are related to burn size. Surgery 1987, 102:808-812.
26. Volk HD, Reinke P, Docke WD. Clinical aspects: from systemic inflammation to 'immunoparalysis'. Chem Immunol 2000, 74:162-177. full_text, 10608087.
27. Strohmeyer JC, Blume C, Meisel C, Doecke WD, Hummel M, Hoeflich C, Thiele K, Unbehaun A, Hetzer R, Volk HD. Standardized immune monitoring for the prediction of infections after cardiopulmonary bypass surgery in risk patients. Cytometry B Clin Cytom 2003, 53:54-62. 10.1002/cyto.b.10031, 12717692.
28. Angele MK, Faist E. Clinical review: immunodepression in the surgical patient and increased susceptibility to infection. Crit Care 2002, 6:298-305. 10.1186/cc1514, 137309, 12225603.
29. Gould EK, Harvey JA, Dytrych JK. Antibody to endotoxin is associated with decreased frequency of postoperative infection. Am J Obstet Gynecol 1989, 160:317-319.
30. Blomquist S, Gustafsson V, Manolopoulos T, Pierre L. Clinical experience with a novel endotoxin adsorbtion device in patients undergoing cardiac surgery. Perfusion 2009, 24:13-17. 10.1177/0267659109106730, 19567543.
31. Aydin NB, Gercekoglu H, Aksu B, Ozkul V, Sener T, Kiygil I, Turkoglu T, Cimen S, Babacan F, Demirtas M. Endotoxemia in coronary artery bypass surgery: a comparison of the off-pump technique and conventional cardiopulmonary bypass. J Thorac Cardiovasc Surg 2003, 125:843-848. 10.1067/mtc.2003.323, 12698147.